Janux Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of JANX for the last quarter is 2.46 M USD, and it's 2.22% lower compared to the previous quarter. The net income of Q4 23 is -11.76 M USD.